Commonest malignancy in renal transplant recipient is
Wait, the core concept is the increased cancer risk due to immunosuppressive therapy. The correct answer is likely PTLD because of EBV reactivation. Let me verify. PTLD is associated with Epstein-Barr virus and occurs in immunosuppressed patients. But some sources say that skin cancers are the most common. Hmm, maybe there's a difference in the time frame. Early post-transplant, PTLD is more common, but long-term, skin cancers like squamous cell carcinoma might be the most common. I need to check which is considered the "commonest" overall.
Looking up some references: According to medical textbooks, the most common malignancy in renal transplant recipients is squamous cell carcinoma of the skin. However, PTLD is the most common non-skin cancer. The question might be asking about all malignancies, including skin. So if the options include both, but the correct answer is PTLD, that might be incorrect. Wait, the user's correct answer is not provided here. The user's correct answer is missing in the input. Oh, the user provided the correct answer as "C. ...", but the options are blank. Wait, the user's input has the correct answer as ". ." which is incomplete. Hmm, maybe they made a mistake. Wait, in the original input, the correct answer is missing. Wait, the user provided the question and the correct answer as "Correct Answer: . " with the letter and answer text missing. So I need to figure out the correct answer based on the question.
Assuming the correct answer is Post-transplant lymphoproliferative disorder (PTLD), but I need to confirm. Let me think: In transplant recipients, the risk of malignancy is increased due to immunosuppression. The most common malignancies are skin cancers (squamous cell carcinoma, basal cell carcinoma) and PTLD. However, PTLD is the most common non-skin cancer. So if the question is asking for the overall commonest, it's skin cancers. But if the options don't include skin cancers and instead include PTLD, then PTLD would be the answer. Since the options are not provided, but the user expects the correct answer to be PTLD, perhaps the question is designed that way.
Alternatively, maybe the correct answer is Kaposi's sarcoma, but that's more associated with HIV. Wait, no, in transplant recipients, Kaposi's can occur but isn't the most common. So, the most common malignancy in renal transplant recipients is skin cancer, particularly squamous cell carcinoma. However, PTLD is the most common non-skin cancer. Therefore, if the question is about the overall most common malignancy, the answer is skin cancer. But if the options don't include skin cancer, then PTLD would be the answer. Since the user hasn't provided the options, I